Biofilm regulation in Clostridioides difficile: Novel systems linked to hypervirulence
Open Access
- 9 September 2021
- journal article
- review article
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 17 (9) , e1009817
Abstract
Clostridiodes difficile (C. difficile) was ranked an “urgent threat” by the Centers for Disease Control and Prevention (CDC) in 2019. C. difficile infection (CDI) is the most common healthcare-associated infection (HAI) in the United States of America as well as the leading cause of antibiotic-associated gastrointestinal disease. C. difficile is a gram-positive, rod-shaped, spore-forming, anaerobic bacterium that causes infection of the epithelial lining of the gut. CDI occurs most commonly after disruption of the human gut microflora following the prolonged use of broad-spectrum antibiotics. However, the recurrent nature of this disease has led to the hypothesis that biofilm formation may play a role in its pathogenesis. Biofilms are sessile communities of bacteria protected from extracellular stresses by a matrix of self-produced proteins, polysaccharides, and extracellular DNA. Biofilm regulation in C. difficile is still incompletely understood, and its role in disease recurrence has yet to be fully elucidated. However, many factors have been found to influence biofilm formation in C. difficile, including motility, adhesion, and hydrophobicity of the bacterial cells. Small changes in one of these systems can greatly influence biofilm formation. Therefore, the biofilm regulatory system would need to coordinate all these systems to create optimal biofilm-forming physiology under appropriate environmental conditions. The coordination of these systems is complex and multifactorial, and any analysis must take into consideration the influences of the stress response, quorum sensing (QS), and gene regulation by second messenger molecule cyclic diguanosine monophosphate (c-di-GMP). However, the differences in biofilm-forming ability between C. difficile strains such as 630 and the “hypervirulent” strain, R20291, make it difficult to assign a “one size fits all” mechanism to biofilm regulation in C. difficile. This review seeks to consolidate published data regarding the regulation of C. difficile biofilms in order to identify gaps in knowledge and propose directions for future study.Keywords
This publication has 105 references indexed in Scilit:
- Modulation of Toxin Production by the Flagellar Regulon in Clostridium difficileInfection and Immunity, 2012
- The Clostridium difficile spo0A Gene Is a Persistence and Transmission FactorInfection and Immunity, 2012
- Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus VancomycinClinical Infectious Diseases, 2012
- Cyclic Diguanylate Inversely Regulates Motility and Aggregation in Clostridium difficileJournal of Bacteriology, 2012
- Localization of the Clostridium difficile Cysteine Protease Cwp84 and Insights into Its Maturation ProcessJournal of Bacteriology, 2011
- Infection of hamsters with the UK Clostridium difficile ribotype 027 outbreak strain R20291Journal of Medical Microbiology, 2011
- Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbationProceedings of the National Academy of Sciences, 2010
- Cannibalism enhances biofilm development in Bacillus subtilisMolecular Microbiology, 2009
- The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genomeNature Genetics, 2006
- Aminoglycoside antibiotics induce bacterial biofilm formationNature, 2005